Nureca

212.62
-0.72
(-0.34%)
Market Cap
212.62 Cr
EPS
-1.79
PE Ratio
-
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
447.50
52 Week Low
206.82
PB Ratio
1.10
Debt to Equity
0.02
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
2,256.00
#1 22,859.08
71.15
#1 1,434.50
24.59
#1 258
#1 31.08
46.56
303.95
1,617.20
55.90
307.90
-0.45
43
-46.46
48.46
442.00
530.54
28.90
59.30
30.58
16
25.00
42.77
101.80
106.24
#1 10.75
109.90
-1.43
10
-
45.06
196.00
104.83
66.67
17.80
#1 136.23
2
-98.33
34.71
125.00
41.30
82.78
14.00
27.27
1
-
84.07
110.00
40.10
49.19
51.30
-2.84
1
-400.00
53.06
39.80
34.47
18.34
32.30
14.13
3
0.50
32.07
64.00
32.30
-
89.80
17.54
-3
-35.71
30.30
Nureca
this company
212.62
#4 212.62
-
#4 102.40
#10 -13.51
#9 -2
#8 -1,500.00
30.65
Growth Rate
Revenue Growth
-13.51 %
Net Income Growth
-78.05 %
Cash Flow Change
-126.49 %
ROE
-78.01 %
ROCE
-79.85 %
EBITDA Margin (Avg.)
-104.50 %

Quarterly Financial Results

Quarterly Financials
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
33
30
93
60
33
122
49
50
43
27
39
30
23
24
35
28
16
26
34
28
Expenses
29
17
56
52
28
72
41
43
44
31
42
29
25
24
30
27
21
23
34
31
EBITDA
4
13
37
9
6
49
8
7
-1
-5
-3
1
-1
-0
5
2
-6
3
1
-3
Operating Profit %
11 %
43 %
39 %
13 %
14 %
39 %
13 %
11 %
-7 %
-22 %
-13 %
-3 %
-16 %
-14 %
4 %
-19 %
-26 %
-12 %
-8 %
-15 %
Depreciation
0
0
0
0
0
0
0
0
1
1
1
1
1
1
1
1
1
1
1
1
Interest
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
3
13
36
9
5
49
8
6
-2
-5
-4
0
-2
-1
4
1
-7
3
-0
-3
Tax
1
3
9
2
1
13
2
2
-1
-1
-1
0
-0
-0
1
1
-2
1
0
-1
Net Profit
2
9
27
6
4
36
5
5
-1
-4
-3
0
-2
-1
3
0
-4
2
-1
-3
EPS in ₹
3.40
13.50
38.19
8.53
4.56
36.20
5.43
4.73
-1.40
-4.13
-2.89
0.30
-1.53
-0.71
2.90
0.16
-4.15
1.66
-0.48
-2.80

Balance Sheet

Balance Sheet
2019
2020
2021
2022
2023
2024
Total Assets
24
34
186
219
207
205
Fixed Assets
1
1
4
10
9
7
Current Assets
23
33
181
206
187
193
Capital Work in Progress
0
0
0
0
0
0
Investments
0
0
0
33
59
94
Other Assets
23
33
182
175
139
104
Total Liabilities
24
34
186
219
207
205
Current Liabilities
15
10
19
12
9
9
Non Current Liabilities
0
9
4
4
3
3
Total Equity
8
15
163
203
195
193
Reserve & Surplus
8
15
153
193
185
183
Share Capital
0
0
10
10
10
10

Cash Flow

Cash Flow
2019
2020
2021
2022
2023
2024
Net Cash Flow
0
0
17
-9
-8
14
Investing Activities
-0
-0
-110
-3
-17
18
Operating Activities
0
-8
35
1
10
-3
Financing Activities
-0
8
92
-7
-2
-1

Share Holding

% Holding
Jan 2020
Feb 2021
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
93.33 %
70.00 %
70.00 %
70.00 %
70.00 %
70.00 %
70.00 %
70.00 %
70.00 %
62.98 %
62.98 %
62.98 %
63.24 %
63.24 %
63.24 %
63.24 %
63.77 %
64.06 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.10 %
0.00 %
0.08 %
0.08 %
0.69 %
0.36 %
DIIs
0.00 %
3.54 %
5.71 %
5.40 %
5.42 %
5.43 %
5.23 %
5.23 %
0.58 %
0.03 %
0.02 %
0.02 %
0.02 %
0.00 %
0.02 %
0.04 %
0.04 %
0.04 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
5.87 %
4.49 %
4.32 %
5.50 %
5.18 %
8.49 %
8.54 %
25.85 %
34.17 %
34.06 %
34.24 %
34.32 %
33.61 %
33.73 %
34.24 %
32.97 %
33.27 %
Others
6.67 %
20.59 %
19.80 %
20.28 %
19.07 %
19.40 %
16.29 %
16.23 %
3.57 %
2.82 %
2.94 %
2.76 %
2.33 %
3.16 %
2.94 %
2.41 %
2.53 %
2.27 %
No of Share Holders
19
8,436
7,827
10,060
12,618
15,471
26,123
26,114
63,911
62,007
58,560
55,569
52,255
49,600
45,996
43,813
41,986
41,314

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 2 3 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.15 1 0.00 0.00 0.00

Corporate Action

Announcements

Nureca Limited Has Informed The Exchange Regarding Revised Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 201510 days ago
Nureca Limited Has Informed The Exchange Regarding Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015Mar 15, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 28, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 28, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 24, 2025
Outcome Of Board Meeting Under Regulation 30 Of SEBI (LODR)Regulations2015Feb 24, 2025
Nureca Limited Has Informed The Exchange Regarding Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations2015. Feb 14, 2025
Nureca Limited Has Informed The Exchange Regarding Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015Feb 04, 2025
Nureca Limited Has Informed The Exchange Regarding Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015Feb 03, 2025
Revised Signed Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015 (PIT Regulations)Jan 31, 2025
Revised Disclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015 (PIT Regulations)Jan 31, 2025
Disclosure Under Regulation 7(2)(A) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015Jan 31, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJan 25, 2025
Integrated Filing (Financial)Jan 24, 2025
Standalone And Consolidated Financial Results For Quarter And Nine Months Ended December 31 2024Jan 24, 2025
Disclosure Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 24, 2025
Appointment of Company Secretary and Compliance OfficerJan 24, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJan 24, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJan 24, 2025
Board Meeting Outcome for Outcome Of Board MeetingJan 24, 2025
Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended December 31 2024Jan 24, 2025
Board Meeting Intimation for Consideration And Approval Of Financial Results For The Third Quarter And Nine Months Ended December 31 2024Jan 17, 2025
Disclosure Under Regulation 30 Of Securities And Exchange Board Of India ("SEBI") (Listing Obligations And Disclosure Requirements) Regulations 2015Jan 08, 2025
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015Dec 30, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseDec 16, 2024
Announcement under Regulation 30 (LODR)-Change in ManagementDec 16, 2024
Announcement under Regulation 30 (LODR)-AcquisitionDec 16, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseDec 14, 2024
Announcement under Regulation 30 (LODR)-Updates on AcquisitionDec 11, 2024
Announcement under Regulation 30 (LODR)-AcquisitionDec 11, 2024
Disclosure Under Regulation 7(2) And Second Proviso To Regulation 4(1)(I) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015Dec 10, 2024
Announcement under Regulation 30 (LODR)-AcquisitionDec 06, 2024
Announcement under Regulation 30 (LODR)-AcquisitionDec 04, 2024
Announcement under Regulation 30 (LODR)-AcquisitionDec 02, 2024
Announcement under Regulation 30 (LODR)-Updates on AcquisitionNov 25, 2024
Announcement under Regulation 30 (LODR)-AcquisitionNov 24, 2024
Announcement under Regulation 30 (LODR)-Change in DirectorateNov 21, 2024
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsNov 16, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 25, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationOct 24, 2024
Financial Results For The Quarter And Half Year Ended September 30, 2024Oct 24, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 24, 2024
Financial Results For The Quarter Ended September 30, 2024Oct 24, 2024
Board Meeting Intimation for Consideration And Approval Of Un-Audited Financial Results (Standalone And Consolidated) Of The Company For The Second Quarter And Half Year Ended September 30, 2024.Oct 17, 2024
Closure of Trading WindowSep 26, 2024
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsSep 17, 2024
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsSep 14, 2024
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsSep 14, 2024
Disclosure Under Regulation 7(2) And Second Proviso To Regulation 4(1)(I) Of SEBI (Prohibition Of Insider Trading) Regulations, 2015Aug 13, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 06, 2024

Technical Indicators

RSI(14)
Neutral
30.65
ATR(14)
Volatile
12.03
STOCH(9,6)
Neutral
29.73
STOCH RSI(14)
Neutral
32.72
MACD(12,26)
Bullish
0.78
ADX(14)
Strong Trend
33.63
UO(9)
Bearish
31.41
ROC(12)
Downtrend And Accelerating
-9.93
WillR(14)
Oversold
-83.77